European patent office
2 articles
Doctors of the World Opposes the Patent on Sofosbuvir
Hepatitis C: scourge, remedy and scandal
This is the first time in Europe that a medical NGO uses this juridical tool to improve patients access to treatment. More
Hepatitis C: Gilead Patent on Sofosbuvir Partially Maintained Following MdM Patent Opposition
Paris, 5 October 2016
European Patent Office (EPO) has taken its decision following Médecins du Monde (MdM) patent opposition on Gilead’s sofosbuvir. MdM applauds EPO’s decision to revoke partially the patent. More
